Biotechnology News

January 17, 2012

WASHINGTON--(BUSINESS WIRE)--Fritz Bittenbender joins BIO as Vice President, Alliance Development and State Government Relations. He will lead state legislative and regulatory issues and engagement with stakeholder organizations.

January 17, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction for Royal Merger Sub II Inc., a wholly-owned subsidiary of Gilead (“Merger Sub II”), to acquire...

January 17, 2012

MIAMI BEACH, Fla.--(BUSINESS WIRE)--The most common disease you’ve never heard of, fibromuscular dysplasia (FMD), frequently goes undetected and can lead to high blood pressure, stroke and aneurysms. Although considered a rare disease, studies...

January 17, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--PV-10 Mechanism of Action data will be presented at the Society of Surgical Oncology Annual Meeting on March 21-24, 2012 during the melanoma poster presentation.

January 17, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals will present at the Noble Financial Capital Markets' Eighth Annual Equity Conference on January 18, 2012 at 1:00 p.m. EST. The presentation will be webcast.

January 17, 2012

ST. LOUIS--(BUSINESS WIRE)--Top 10 Pharma selects D360 as its enterprise solution for conducting single-study and cross-study search and analysis of preclinical safety data.

January 17, 2012

MIAMI--(BUSINESS WIRE)--Data presented at the 6th Annual Human Amyloid Imaging (HAI) meeting in Miami suggest that the investigational imaging agent [18F] Flutemetamol could add value to current diagnostic tools used by physicians to evaluate...

January 17, 2012

NEW YORK--(BUSINESS WIRE)--ePharma Consumer® Study Reveals New Trends around How Consumers Interact with Pharma, Including Customer Service Options, Patient Education, and Pharma Websites – Webinar January 25 at 2pm ET

January 17, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced that it has listed its Infinity Series 1200 liquid chromatography systems and 6000 Series mass spectrometry systems as Class I medical devices with the U.S....

January 17, 2012

LONDON--(BUSINESS WIRE)--Edison has published a report examining the investment merits of Transgene (TNG), focusing on the potential of its four lead immunotherapy products for various cancers and infectious diseases

January 17, 2012

CLEVELAND--(BUSINESS WIRE)--ImageIQ, an imaging contract research organization, is offering a scholarship for students who demonstrate unique applications of imaging in bioscience

January 17, 2012

TROMSO, Norway--(BUSINESS WIRE)--ArcticZymes AS announced today the formation of ArcticZymes Inc. a wholly owned subsidiary located in Plymouth Meeting, PA. The Company designs, manufactures, and commercializes cold water adapted enzymes for use...

January 17, 2012

MADISON, Wis.--(BUSINESS WIRE)--Mirus Biosciences, LLC' filed a dismissal with prejudice in the Mirus Biosciences, LLC v. Fugent, LLC patent litigation that was pending in the Federal District Court for the Western District of WI

January 17, 2012

SOMERSET, N.J.--(BUSINESS WIRE)--Alliance Life Sciences Consulting Group will be sponsoring the 2012 CBI Compliance Congress and releasing a new White Paper on the proposed rules for Sunshine Act Implementation.

January 17, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex (Nasdaq: VRTX) will announce its fourth quarter and full year 2011 financial results on Thursday, February 2, 2012 after the financial markets close.

January 17, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has filed a patent infringement lawsuit against Tekmira Pharmaceuticals Corporation in the U.S. District...

January 17, 2012

SAN JOSE, Calif.--(BUSINESS WIRE)--NDS Surgical Imaging launches the first video scaling appliance for the operating room environment

January 17, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, today announced that the Wills Eye Institute in Philadelphia has received institutional review board (IRB)...

January 17, 2012

NEW PRAGUE, Minn.--(BUSINESS WIRE)--After reporting a strong First Quarter FY2012 ended September 30, 2011, in which Sales advanced 29% versus the comparable prior Fiscal Year Quarter, Electromed, Inc. (NYSE Amex: ELMD) announces the following...

January 17, 2012

SAN DIEGO--(BUSINESS WIRE)--AI BioTech Selects XIFIN for Revenue Cycle Management

January 17, 2012

ALBANY, N.Y. & MILWAUKEE--(BUSINESS WIRE)--Bionime will offer innovative GE-branded clinical and home-based patient care products for the rapidly growing global diabetes population

January 17, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--OpGen, Inc., a whole-genome analysis company developing and commercializing a complete suite of break-through products and services based on its proprietary Whole Genome Mapping technology, announced today that...

January 17, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)--A live and archived webcast of Opexa Therapeutics CEO Neil K. Warma's presentation at the Noble Financial Capital Markets Conference is availble at...

January 17, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River schedules fourth-quarter 2011 earnings call for February 14th at 8:30am ET

January 17, 2012

BOSTON--(BUSINESS WIRE)--A collection of innovative bio-based chemicals & materials start-ups is rapidly maturing and attaining scale, causing the biggest change in the chemicals industry in decades according to Lux Research.

January 17, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic Inc. (NYSE: MDT) today announced the CE (Conformité Européenne) mark and international launch of the Endurant® II AAA Stent Graft System, which meaningfully expands the options physicians outside the United...

January 17, 2012

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical manufacturer and marketer, today announced that reported earnings per share were $1.04 in the third quarter of fiscal 2012. Reported earnings per...

January 17, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that dosing has initiated in a Phase 1 study of its hematopoietic growth factor, CDX-301, in healthy subjects. The study is being conducted in...

January 17, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”) (OTCBB: IMUC.OB), an emerging biotechnology company focused on developing novel-immune-based therapies, today announced that its President and CEO...

January 17, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing oncology and CNS therapeutics, today provided guidance on its key pipeline, scientific and business goals for...

January 17, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex: AIS) today announced that it has licensed exclusively its Oxybutynin Gel 3% to Daewoong Pharmaceuticals Co. Ltd.,for marketing in South Korea. Antares will receive undisclosed upfront...

January 17, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule announces Phase 2 trial data with tivantinib in hepatocellular carcinoma.

January 17, 2012

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed Presents Ground-Breaking Data in Proteome Dynamics and Tissue Flux Imaging at the 2012 Personalized Medicine World Conference

January 17, 2012

SAN FRANCISCO & NEW YORK--(BUSINESS WIRE)--Medivation, Inc. (NASDAQ: MDVN) and Pfizer Inc. (NYSE: PFE) today announced results from the CONCERT trial, which is a Phase 3 trial that evaluated dimebon (latrepirdine) when added to ongoing...

January 17, 2012

BERLIN--(BUSINESS WIRE)--JPT Peptide Technologies GmbH (JPT), a wholly-owned subsidiary of BioNTech AG (Mainz, Germany), IUCT and LEITAT (Barcelona, Spain) announced today their collaboration on the joint development of an enhanced anticancer...

January 17, 2012

NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica has signed a new agreement with Harrison Clinical Research, an international full-service contract research organization, for BioClinica OnPoint CTMS.

January 17, 2012

CAMBRIDGE, Mass. & DANVILLE, Pa.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), and Geisinger Health System today announced a...

January 17, 2012

CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--MGB Biopharma and Almac’s Sciences Business Unit have entered into a collaboration where Almac will manufacture the production of their lead gram positive antibacterial compound MGB-BP3. The compound...

January 17, 2012

GENGENBACH & GREIFSWALD, Germany--(BUSINESS WIRE)--"We are happy to establish processes from development via production to market entry together with Herbrand PharmaChemicals" states Dr. Menyes from Enzymicals AG while visiting the running...

January 17, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC: Biotech Growing Faster than any Other Sector in Houston

January 17, 2012

HALLE, Germany--(BUSINESS WIRE)--Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today that it has signed a supply agreement with Actavis, one of the world's...

January 17, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) today announced that Robert E. Conway has resigned as Chief Executive Officer and a Director for personal reasons. The Board has appointed Kyle Lefkoff, Chairman of the Board,...

January 17, 2012

PARIS--(BUSINESS WIRE)--Cegedim Relationship Management today announced that Ferring Pharmaceuticals (Asia) Company Limited has fully implemented Mobile Intelligence™ as their centralized Customer Relationship Management (CRM) platform to manage...

January 17, 2012

MIAMI BEACH, Fla.--(BUSINESS WIRE)--Although using angioplasty to treat multiple sclerosis (MS) is highly controversial, sufferers often insist it helps – in some cases dramatically, such as allowing them to walk without a cane. Patients with...

January 17, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Ganetespib,enhances the activity of the microtubule targeting docetaxel, paclitaxel, and vincristine in multiple non-small cell lung cancer (NSCLC) xenograft models according to an article published.

January 17, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends releases findings from report measuring Zytiga’s market impact at six months following approval

January 17, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--The Avance® Nerve Graft achieved meaningful recovery in 87 percent of patients with peripheral nerve injuries.

January 17, 2012

SOUTH SAN FRANCISCO, Calif. & ST. LOUIS--(BUSINESS WIRE)--MOgene, LC, a leading genomics service provider located in St. Louis, is implementing Fluidigm Access Array™ sample preparation technology for its targeted resequencing customers.